openPR Logo
Press release

A 'Silver Lining' for Ascending Thoracic Aortic Aneurysms

09-29-2025 02:07 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Thoracic Aortic Aneurysm Market

Thoracic Aortic Aneurysm Market

Introduction
A thoracic aortic aneurysm (TAA) is a serious cardiovascular condition characterized by abnormal dilation of the aorta within the chest, which can lead to life-threatening complications if left untreated, including dissection and rupture. Risk factors include hypertension, atherosclerosis, connective tissue disorders, and genetic syndromes such as Marfan and Loeys-Dietz.

Although TAAs are relatively rare compared to abdominal aortic aneurysms, they carry high morbidity and mortality risks. Early detection through imaging and advancements in minimally invasive surgical techniques have improved survival rates. Over the next decade, the thoracic aortic aneurysm market is expected to expand, driven by rising cardiovascular disease prevalence, growing adoption of endovascular procedures, and advances in stent graft technology.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72670

Market Overview
• The global thoracic aortic aneurysm market size in 2024 is estimated at USD 2.4 billion.
• It is projected to reach USD 5.8 billion by 2034, growing at a CAGR of 9.1 % during the forecast period.
• Market growth is supported by increasing awareness, technological advancements, and rising demand for minimally invasive procedures.

Key Market Drivers:
• Increasing prevalence of hypertension and atherosclerosis worldwide.
• Advancements in imaging techniques (CT, MRI, echocardiography).
• Growing adoption of thoracic endovascular aortic repair (TEVAR).
• Expanding aging population at higher risk of aneurysms.

Key Challenges:
• High cost of advanced surgical and endovascular procedures.
• Limited access to specialized treatment centers in developing countries.
• Risk of complications such as endoleaks and stent graft migration.

Leading Players:
Medtronic plc, Cook Medical, W. L. Gore & Associates, Terumo Aortic, Endologix LLC, CryoLife, and Cardinal Health.

Segmentation Analysis
The thoracic aortic aneurysm market can be segmented as follows:
By Treatment Type
• Open Surgical Repair
• Endovascular Repair (TEVAR)
• Hybrid Procedures

By Product Type
• Stent Grafts
• Graft Prosthetics
• Others

By End-Use
• Hospitals
• Specialty Cardiac Centers
• Academic & Research Institutes

Summary:
Endovascular repair (TEVAR) is the fastest-growing treatment type, offering minimally invasive alternatives with reduced recovery times. Stent grafts dominate the product segment, driven by continuous technological innovations. Hospitals remain the primary treatment centers, while specialty cardiac centers are expanding due to focused expertise.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72670/thoracic-aortic-aneurysm-market

Regional Analysis
North America
• Largest market, contributing ~45 % of global revenues in 2024.
• Driven by advanced cardiovascular infrastructure, high disease awareness, and early adoption of TEVAR.
• Strong presence of leading device manufacturers like Medtronic and Gore.
Europe
• Germany, France, and the UK lead with robust cardiovascular programs.
• EMA approvals and government initiatives supporting early diagnosis enhance adoption.
Asia-Pacific (APAC)
• Expected to record the fastest CAGR (~10.7 %) from 2024-2034.
• Rising incidence of hypertension and lifestyle-related disorders in China, India, and Japan.
• Expanding hospital infrastructure and increasing adoption of minimally invasive procedures.
Middle East & Africa (MEA)
• Early adoption, but high unmet need due to limited cardiac centers.
• GCC countries investing in advanced cardiovascular surgery programs.
Latin America
• Brazil and Mexico drive regional demand, supported by public and private healthcare investments.

Regional Summary:
North America and Europe dominate today's revenues, but Asia-Pacific is the fastest-growing market, with growing awareness, government health initiatives, and investment in advanced cardiovascular care.

Market Dynamics
Growth Drivers
1. Rising cardiovascular disease burden worldwide.
2. Technological advancements in stent grafts and imaging modalities.
3. Increasing demand for minimally invasive TEVAR procedures.
4. Expansion of cardiovascular research and screening programs.

Key Challenges
• Procedural risks including graft migration, endoleaks, and reinterventions.
• High treatment costs, particularly in emerging economies.
• Limited trained specialists for complex TAA surgeries.

Latest Trends
• Development of next-generation branched and fenestrated stent grafts.
• Increasing use of AI in imaging diagnostics for early aneurysm detection.
• Growth of patient-specific graft customization using 3D printing.
• Expansion of hybrid surgical-endovascular procedures.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72670

Competitor Analysis
Major Players:
• Medtronic plc - Leading in endovascular stent graft technology.
• Cook Medical - Strong portfolio in aortic repair devices.
• W. L. Gore & Associates - Innovative stent graft systems.
• Terumo Aortic - Hybrid and open surgical repair solutions.
• Endologix LLC - Advanced minimally invasive repair technologies.
• CryoLife - Cardiovascular grafts and surgical products.
• Cardinal Health - Distribution and support for cardiovascular devices.

Competitive Summary:
The market is moderately consolidated, with leading device manufacturers dominating global revenues. Innovation in stent graft design, hybrid solutions, and AI-driven imaging partnerships are shaping competition. Collaborations with hospitals and research institutes remain essential for clinical adoption and regulatory approval.

Conclusion
The thoracic aortic aneurysm market is projected to grow from USD 2.4 billion in 2024 to USD 5.8 billion by 2034, at a CAGR of 9.1 %.

This report is also available in the following languages : Japanese (胸部大動脈瘤市場), Korean (흉부 대동맥류 시장), Chinese (胸主动脉瘤市场), French (Marché des anévrismes de l'aorte thoracique), German (Markt für thorakale Aortenaneurysmen), and Italian (Mercato dell'aneurisma aortico toracico), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72670

Our More Reports:

Long Acting Drugs Market
https://exactitudeconsultancy.com/reports/72608/long-acting-drugs-market

Smart Labels Market
https://exactitudeconsultancy.com/reports/72610/smart-labels-market

SARM1 Inhibitor Market
https://exactitudeconsultancy.com/reports/72612/sarm1-inhibitor-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A 'Silver Lining' for Ascending Thoracic Aortic Aneurysms here

News-ID: 4202318 • Views:

More Releases from Exactitude Consultancy

Amnesia Market Growth: $3.5B in 2024 to $6.7B by 2034
Amnesia Market Growth: $3.5B in 2024 to $6.7B by 2034
The Amnesia market is set to expand at a CAGR of 6.8%, driven by growing prevalence of neurological disorders and advances in diagnostic and treatment options. Introduction: The Amnesia Market is projected to grow significantly, reaching a market value of $6.7 billion by 2034, up from $3.5 billion in 2024. This growth is driven by an increase in neurological disorders, advancements in cognitive treatments, and a growing demand for cognitive training devices,
Pharma Contract Research Organization (CRO) Services Market Growth: $52B in 2024 to $85B by 2034
Pharma Contract Research Organization (CRO) Services Market Growth: $52B in 2024 …
The Pharma CRO Services market is expected to witness a robust CAGR of 6.1% from 2024 to 2034, driven by increased demand for outsourcing and rising drug development complexities. Introduction: The global Pharma Contract Research Organization (CRO) Services Market is projected to grow significantly, reaching $85 billion by 2034, up from $52 billion in 2024. This growth is primarily driven by the outsourcing trend within the pharmaceutical industry, the increasing complexity of
Neuroendocrine Breast Tumor Market to Reach USD 4.5 Billion by 2034, Growing at a CAGR of 7.5%
Neuroendocrine Breast Tumor Market to Reach USD 4.5 Billion by 2034, Growing at …
Exactitude Consultancy's new report explores the growth of the Neuroendocrine Breast Tumor Market, driven by advancements in diagnostic methods, targeted therapies, and increasing research investments. Introduction: Exactitude Consultancy's latest market research report on the Neuroendocrine Breast Tumor Market forecasts strong growth from USD 2.3 billion in 2024 to USD 4.5 billion by 2034, growing at a CAGR of 7.5%. The market is driven by improvements in diagnostic technologies, increasing research into targeted
Cutaneous Lupus Market to Reach USD 2.6 Billion by 2034, Growing at a CAGR of 8.1%
Cutaneous Lupus Market to Reach USD 2.6 Billion by 2034, Growing at a CAGR of 8. …
Exactitude Consultancy's new report explores the increasing growth of the Cutaneous Lupus Market, driven by advancements in treatment options, diagnostic tools, and rising awareness. Introduction: Exactitude Consultancy's latest market research report on the Cutaneous Lupus Market forecasts significant growth from USD 1.2 billion in 2024 to USD 2.6 billion by 2034, growing at a CAGR of 8.1%. The market is driven by improvements in treatment strategies, increasing awareness of cutaneous lupus, and

All 5 Releases


More Releases for Aortic

Rising Incidence Of Aortic Aneurysms Fuels Expansion Of Aortic Endograft Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Aortic Endograft Market Size Growth Forecast: What to Expect by 2025? There has been significant growth in the size of the aortic endograft market in recent years. The market is projected to expand from $3.35 billion in 2024 to $3.52 billion in 2025, corresponding to a compound annual growth
Intra Aortic Balloon Pumps Market
Intra-aortic balloon pumps (IABP) are medical devices used to support heart function in patients with severe coronary artery disease, heart failure, or other cardiovascular conditions. These devices work by inflating and deflating a balloon placed in the aorta, which helps improve blood flow to the heart and vital organs. IABPs are primarily used in critical care settings, including cardiac surgery, heart attack recovery, and as a bridge to more definitive
Intra-Aortic Balloon Pump Market Clearly identifies the medical device focus. In …
InsightAce Analytic Pvt. Ltd. announced the addition of new market research report in its portfolio. 'Global Intra-aortic Balloon Pump Market Assessment - Revenue and Volume Forecast, Historic Revenue and Forecast Till 2028 Global Intra-aortic Balloon Pump market report is segmented based on product type, application and geography. Based upon product type Global Intra-aortic Balloon Pump Market is classified as Product iPulse,Corart BP3,Cardiosave, CS,Corart BP3, ULTRA 7FR,Sensation Catheter ,LINEAR Catheter ,MEGA Catheter Get
Aortic Aneurysm Market - Transforming the Aortic Aneurysm Landscape: Redefining …
Newark, New Castle, USA: The "Aortic Aneurysm Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Aortic Aneurysm Market: https://www.growthplusreports.com/report/aortic-aneurysm-market/8565 This latest report researches the industry structure, sales,
Rising Prevalence of Aortic Aneurysms Driving the Aortic Intervention Market
The global 𝐀𝐨𝐫𝐭𝐢𝐜 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧 market is estimated to attain a significant valuation by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand during the forecast period, 2021 - 2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Aortic Intervention industry. The current
Aortic Stents Grafts Market: Rising Prevalence of Aortic Aneurysm to Fuel the Gr …
The Aortic Stents Grafts Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. View Report - https://www.theinsightpartners.com/reports/aortic-stent-graft-market/ Aortic Stents Grafts is a new option for treatment of